Karma,I think that everybody here expects the trials to be successful.However there is always the small possibility that something could go wrong.Even Al says...

"Of course, registration trials are complex and there are always risks, but in the real world of diabetes therapy, I have no doubt that the AFREZZA to be far more effective than just a better prandial insulin in basal/bolus therapy."